{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-000516","form_type":"8-K","ticker":"CBIO","cik":"0001253689","company_name":"CRESCENT BIOPHARMA, INC.","filed_at":"2022-01-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.705603+00:00","generated_at":"2026-06-27T14:47:41.571733+00:00","sec_items":["5.02","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"GlycoMimetics awards retention bonuses to CFO, CBO, CSO; induces plan shares to 3M","bullets":["CFO Brian Hahn and CBO Armand Girard eligible for retention bonus up to 60% of base salary; CSO John Magnani up to 20%.","40% of bonus payable Aug 1, 2022; remaining 60% payable Aug 1, 2023, contingent on continued employment through each date.","Inducement Plan share reserve increased from 2M to 3M shares to support equity awards."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-000516","json":"https://secwatch.observer/filing/0001558370-22-000516.json","markdown":"https://secwatch.observer/filing/0001558370-22-000516.md","text":"https://secwatch.observer/filing/0001558370-22-000516.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1253689/000155837022000516/0001558370-22-000516-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1253689/000155837022000516/glyc-20220121x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T14:47:41.571733+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}